Publications by authors named "Hadis Williams"

Claim this Profile
C
Correction: Pharmacokinetic evaluation of single-dose migalastat in non-Fabry disease subjects with ESRD receiving dialysis treatment, and use of modeling to select dose regimens in Fabry disease subjects with ESRD receiving dialysis treatment.
Franklin K Johnson, Shirley Wu, Ginny Schmith, Hadis Williams, Jasmine Rutecki

PLoS One· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic evaluation of single-dose migalastat in non-Fabry disease subjects with ESRD receiving dialysis treatment, and use of modeling to select dose regimens in Fabry disease subjects with ESRD receiving dialysis treatment.
Franklin K Johnson, Shirley Wu, Ginny Schmith, Hadis Williams, Jasmine Rutecki

PLoS One· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of podocyte globotriaosylceramide content in adult male patients with Fabry disease with amenable mutations following 6 months of migalastat treatment.
Michael Mauer, Alexey Sokolovskiy, Jay A Barth, Jeffrey P Castelli, Hadis N Williams

J Med Genet· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat.
Elfrida R Benjamin, Maria Cecilia Della Valle, Xiaoyang Wu, Evan Katz, Farhana Pruthi, Hadis Williams

Genet Med· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lysosomal dysfunction in a mouse model of Sandhoff disease leads to accumulation of ganglioside-bound amyloid-β peptide.
Serene Keilani, Yi Lun, Anthony C Stevens, Hadis N Williams, Eric R Sjoberg

J Neurosci· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis